Bitter Pill: US opioid crisis remains despite settlement Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's opioid epidemic, writes Adam Maguire. Business • 18 Feb
Bitter Pill: US opioid crisis remains despite settlement Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's opioid epidemic, writes Adam Maguire. Business • 18 Feb
'Zombie drug' adding to opioid crisis in US A tranquilliser approved for veterinary use has infiltrated the illegal drug market in the United States, with producers increasingly using it to augment fentanyl. US • 20 Jun 23
'Zombie drug' adding to opioid crisis in US A tranquilliser approved for veterinary use has infiltrated the illegal drug market in the United States, with producers increasingly using it to augment fentanyl. US • 20 Jun 23
J&J to pay $40.5m to settle New Hampshire opioid action Johnson & Johnson has agreed to pay $40.5 million to settle New Hampshire's claims over the company's role in the opioid epidemic, averting a trial that had been scheduled to begin next week. US • 01 Sep 22
J&J to pay $40.5m to settle New Hampshire opioid action Johnson & Johnson has agreed to pay $40.5 million to settle New Hampshire's claims over the company's role in the opioid epidemic, averting a trial that had been scheduled to begin next week. US • 01 Sep 22
Drug companies reach opioid settlement Four large drug companies have today reached a last-minute $260m legal settlement over their role in the US opioid addiction epidemic. Business • 21 Oct 19
Drug companies reach opioid settlement Four large drug companies have today reached a last-minute $260m legal settlement over their role in the US opioid addiction epidemic. Business • 21 Oct 19
